Stocks of the Hour: QX Resources, Antisense Therapeutics, West Wits Mining
Stocks of the Hour: QX Resources, Antisense Therapeutics, West Wits Mining
QX Resources (ASX:QXR) announced that discussions and due diligence have advanced on the Liberty Lithium Brine Project in the California, USA. Commenting on this announcement, CEO, stephen prominitz stated, "Ongoing studies, detailed due diligence and a site visit show QXR that the Liberty Lithium Project is truly large scale with repeatable results and a pathway to development." Shares are trading 4.35 per cent higher at 2.4 cents
QX Resources(澳大利亞證券交易所股票代碼：QXR)宣佈，有關美國加利福尼亞州Liberty鋰鹵水專案的討論和盡職調查已取得進展。在評論這一聲明時，首席執行官斯蒂芬·阿羅裡茨表示：“正在進行的研究、詳細的盡職調查和實地考察表明，QXR公司的Liberty鋰專案規模確實很大，結果可重複，是一條通往發展的道路。”股價上漲4.35%，至2.4美分
Antisense Therapeutics (ASX:ANP | US OTC:ATHJY | FSE:AWY) announced strong results from their positive new DMD Combination Therapy Data in mdx mice. In response, Dr George Tachas, the Director of Drug Discovery and Patents said, "These study results are exciting and suggest the potential for ATL1102 in combination with dystrophin restoration drugs to improve therapeutic outcomes in DMD patients." Shares are trading 5.56 per cent higher at 5.7 cents.
反義治療公司(ASX：ANP|US OTC：ATHJY|FSE：AWY)宣佈了他們在MDX小鼠身上獲得的陽性新DMD聯合治療數據的強勁結果。對此，董事藥物發現和專利部負責人喬治·塔卡斯博士表示：“這些研究結果令人振奮，表明ATL1102與抗肌營養不良蛋白修復藥物聯合使用有潛力改善DMD患者的治療效果。”該公司股價上漲5.56%，至5.7美分。
West Wits Mining (ASX:WWI) has updated its DFS for the Witwatersrand Basin Project in Johannesburg, South Africa. In response, Chairman, Michael Quinert said, "With an impressive increase of US$254 million (95%) in Free Cashflow, the project is set to generate US$522 million." Shares are trading 16.67 at 2.1 cents.
West Wits礦業公司(澳大利亞證券交易所股票代碼：WWI)更新了位於南非約翰內斯堡的Witwater srand盆地專案的DFS。作為回應，董事長Michael Quinert說：“隨著自由現金流令人印象深刻地增加2.54億美元(95%)，該專案將產生5.22億美元的收入。該公司股票目前的交易價格為2.1美分，為16.67美元。
譯文內容由第三人軟體翻譯。